STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[S-8] Flora Growth Corp. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8
Rhea-AI Filing Summary

Flora Growth Corp. is registering 51,282 additional common shares for issuance under its 2022 Incentive Compensation Plan. These shares are reserved for future equity awards to employees, directors and other eligible participants, and none had been issued as of the filing date. The plan, which has been amended several times, uses the same class of common shares that Flora Growth previously registered on earlier Form S-8 filings, and this new statement incorporates those prior registrations by reference.

Positive
  • None.
Negative
  • None.

As filed with the Securities and Exchange Commission on November 18, 2025

Registration No. 333-_______

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM S-8

REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933


FLORA GROWTH CORP.

(Exact name of Registrant as specified in its charter)


Ontario, Canada Not Applicable
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
   
 3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, Florida
33309
(Address of Principal Executive Offices) (Zip Code)

Flora Growth Corp. 2022 Incentive Compensation Plan, as amended on June 6, 2023, August 14, 2024 and June 30, 2025

(Full Title of the Plan)


Dany Vaiman

Chief Financial Officer

3230 W. Commercial Boulevard, Suite 180

Fort Lauderdale, Florida 33309

(Name and address of agent for service)

(954) 842-4989

(Telephone number, including area code, of agent for service)


Copies to:

Richard Raymer

Toronto-Dominion Centre

66 Wellington St. W, Suite 3400

Toronto, ON M5K 1E6, Canada

Telephone: (416) 367-7388


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

EXPLANATORY NOTE

This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 51,282 shares of common shares, no par value per share (the "Common Shares") of Flora Growth Corp. (the "Registrant" or "Company") issuable under the Flora Growth Corp. 2022 Incentive Compensation Plan, as amended on June 6, 2023, August 14, 2024 and June 30, 2025 (the "Plan"), none of which have been issued as of the date of this Registration Statement. These additional Common Shares are securities of the same class as other securities for which the Registrant previously filed Form S-8 Registration Statement for with the Securities and Exchange Commission (the "SEC") on September 10, 2024 (File No. 333-282022), November 15, 2023 (File No. 333-275576) and July 29, 2022 (File No. 333-266400).


INCORPORATION BY REFERENCE OF CONTENTS

OF REGISTRATION STATEMENTS ON FORM S-8

Pursuant to General Instruction E of Form S-8, the contents of the Registration Statements on Form S-8 filed with the SEC on September 10, 2024 (File No. 333-282022), November 15, 2023 (File No. 333-275576) and July 29, 2022 (File No. 333-266400) are incorporated by reference herein.

Item 8. Exhibits.


Exhibit
Number
  Description
     
4.1   Articles of Incorporation of Flora Growth Corp. (incorporated by reference to Exhibit 2.1 of the Company's Form 1-A filed with the SEC on October 11, 2019).
     
4.2   Articles of Amendment of Flora Growth Corp., effective April 30, 2021 (incorporated by reference to Exhibit 3.3 of the Company's Form F-1 filed with the SEC on November 16, 2021).
     
4.3   Bylaw No. 1-A of Flora Growth Corp. (incorporated by reference to Exhibit 99.3 of the Company's Report on Form 6-K filed with the SEC on July 6, 2022).
     
4.4   Articles of Amendment of Flora Growth Corp. effective June 9, 2023 (incorporated by reference to Exhibit 3.1 of the Company's Form 8-K filed with the SEC on June 7, 2023).
     
4.5   Articles of Amendment of Flora Growth Corp. effective August 3, 2025 (incorporated by reference to Exhibit 3.1 of the Company's Form 8-K filed with the SEC on August 4, 2025).
     
4.6*   Flora Growth Corp. 2022 Incentive Compensation Plan, as amended on June 6, 2023, August 14, 2024 and June 30, 2025.
     
5.1*   Opinion of Fogler, Rubinoff LLP.
     
23.1*   Consent of Davidson & Company LLP, independent registered certified public accounting firm.
     
23.2*   Consent of Fogler, Rubinoff LLP (contained in legal opinion filed as Exhibit 5.1).
     
24.1*   Powers of Attorney (included on the signature page to this Registration Statement).
     
107*   Filing Fee Table

* Filed herewith.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Fort Lauderdale, Florida, on this 18th day of November, 2025.

  Flora Growth Corp.
     
  By: /s/ Dany Vaiman
    Name: Dany Vaiman
    Title: Chief Financial Officer



POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Daniel Reis-Faria and Dany Vaiman and each of them, with full power of substitution and full power to act without the other, his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

Signature   Title   Date
         
/s/ Daniel Reis-Faria   Chief Executive Officer and Director
(Principal Executive Officer)
  November 18,
2025
Daniel Reis-Faria    
         
/s/ Dany Vaiman   Chief Financial Officer
(Principal Financial and Accounting Officer)
  November 18,
2025
Dany Vaiman    
         
/s/ Michael Heinrich   Executive Chairman and Director   November 18,
2025
Michael Heinrich    
         
/s/ Edward Woo   Director   November 18,
2025
Edward Woo    
         
/s/ Manfred Leventhal   Director   November 18,
2025
Manfred Leventhal    


Flora Growth Corp

NASDAQ:FLGC

FLGC Rankings

FLGC Latest News

FLGC Latest SEC Filings

FLGC Stock Data

5.52M
618.12k
12.54%
4.08%
1.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
FORT LAUDERDALE